Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases  Johnny H. Hu, Kevin M. Davis, David R.

Slides:



Advertisements
Similar presentations
Lecture-7 Genome editing CRISPR
Advertisements

DNA Repair DNA repair is a system used to correct DNA damage caused by either: A- Errors during DNA replication including incorrect base-pairing (mismatching.
Genome Editing by Matthew Porteus Department of Pediatrics,
WORKSHOP: CRISPR in insects
Genome editing to breed better plants
METHODS OF GENOME ENGINEERING: A NEW ERA OF MOLECULAR BIOLOGY
Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Institute of Health and Biomedical Innovation
Presented by : S.Rasoulinejad
Pluripotent stem cell based gene therapy for hematological diseases
Lecture 16 The future of plant biotechnology: genome editing and concluding perspectives Neal Stewart & Agnieska Piatek.
Volume 22, Issue 7, Pages (July 2015)
Expanding the Biologist’s Toolkit with CRISPR-Cas9
MSc Student Of Hematology
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Xiaoyu Chen, Manuel A.F.V. Gonçalves  iScience 
Virginia J. Bruce, Brian R. McNaughton  Cell Chemical Biology 
In vivo optimization of the tagging approach using the Act5C model locus and flow cytometry-based quantification of the Act5C-GFP tagging success. In vivo.
Rewiring Cas9 to Target New PAM Sequences
Figure 2 Use of CRISPR/Cas9 for genome editing
Development and Applications of CRISPR-Cas9 for Genome Engineering
CRISPR CRISPRs (clustered regularly interspaced short palindromic repeats) are repetitive nucleotide sequences followed by a short spacer DNA segments.
Harnessing CRISPR–Cas systems for bacterial genome editing
Gaelen T. Hess, Josh Tycko, David Yao, Michael C. Bassik 
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Addison V. Wright, James K. Nuñez, Jennifer A. Doudna  Cell 
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology  Joan Ramon Guitart, Jodi L. Johnson,
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Feasibility of new breeding techniques for organic farming
Figure 1 Adaptive immune system of bacteria and archaea
Molecular Therapy - Nucleic Acids
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Therapeutic editing of hepatocyte genome in vivo
USH2A Gene Editing Using the CRISPR System
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
Joseph Bondy-Denomy, Alan R. Davidson  Trends in Microbiology 
CRISPR genome-editing: A medical revolution
Volume 164, Issue 1, Pages (January 2016)
RNA-Guided Genome Editing in Plants Using a CRISPR–Cas System
RNAi: Prokaryotes Get in on the Act
CRISPR: What is it? Biotech Ethics, Fall ‘18.
Volume 154, Issue 6, Pages (September 2013)
Zinc Fingers, TAL Effectors, or Cas9-Based DNA Binding Proteins: What’s Best for Targeting Desired Genome Loci?  Annett Strauβ, Thomas Lahaye  Molecular.
Current Progress in Therapeutic Gene Editing for Monogenic Diseases
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
The Evolution of Antiviral Defense Systems
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
Advances in Industrial Biotechnology Using CRISPR-Cas Systems
Molecular Therapy - Methods & Clinical Development
A CRISPR Approach to Gene Targeting
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Ignazio Maggio, Manuel A.F.V. Gonçalves  Trends in Biotechnology 
Volume 23, Issue 3, Pages (March 2015)
Gene editing: modifying a gene that was already there
Scholarship Symposium
Next Presentation = GMO or Gene-edited plants
Development and Applications of CRISPR-Cas9 for Genome Engineering
Ciaran M Lee, Thomas J Cradick, Gang Bao  Molecular Therapy 
CRISPR/Cas Systems towards Next-Generation Biosensing
Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence replacement. Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence.
CRISPR/Cas9: Transcending the Reality of Genome Editing
Allen R. Buskirk, David R. Liu  Chemistry & Biology 
The Biology of CRISPR-Cas: Backward and Forward
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off- target Effects in Genome Editing  Ciaran M Lee, Thomas J Cradick,
New Tools for Genome Modification in Human Embryonic Stem Cells
CRISPR Craze to Transform Cardiac Biology
CRISPR: What is it? Self & World: Impact of Technological
Engineering Globin Gene Expression
Presentation transcript:

Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases  Johnny H. Hu, Kevin M. Davis, David R. Liu  Cell Chemical Biology  Volume 23, Issue 1, Pages 57-73 (January 2016) DOI: 10.1016/j.chembiol.2015.12.009 Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 1 DNA Cleavage by Zinc-Finger Nucleases, Transcription Activator-like Effector Nucleases, and the Clustered Regularly Interspaced Short Palindromic Repeat-Cas9 System (A) Once a programmable nuclease catalyzes double-stranded DNA cleavage, endogenous cellular non-homologous end-joining (NHEJ) or homology-directed repair (HDR) processes mediate DNA modification at the cleaved locus. While NHEJ yields small, random insertions or deletions (indels) at the cleavage site, HDR uses a separate single- or double-stranded DNA molecule as a template for the precise replacement of bases spanning the site of cleavage. (B) Zinc-finger nucleases contain repeats of zinc-finger domains, each of which recognizes 3 bp of DNA. By fusing the DNA-binding domain to a FokI nuclease, a dimeric ZFN recognizes and cleaves DNA containing adjacent left and right half-sites. (C) TALENs consist of an array of 33- to 35-amino acid TALE domains fused to FokI nuclease. DNA specificity is determined by two amino acids, known as the repeat-variable di-residues (RVDs), within each TALE domain. By simply linking TALE modules together, TALENs can be programmed to recognize virtually any DNA sequence. Like ZFNs, TALENs are designed to recognize a left and right half-site. Upon DNA binding, FokI domain dimerization enables double-stranded DNA cleavage. (D) The CRISPR-Cas9 system is an RNA-programmed endonuclease. The guide RNA (gRNA) contains both the sequence necessary to bind to the Cas9 protein and a “spacer” sequence that binds to the target DNA following Watson-Crick base-pairing rules. By altering the spacer sequences in the gRNA, Cas9 can be targeted to virtually any DNA sequence that contains a short protospacer adjacent motif (PAM) downstream of the DNA target. The most commonly used S. pyogenes Cas9 makes a double-stranded cut 3–4 bp away from the PAM as indicated by the arrowheads. Cell Chemical Biology 2016 23, 57-73DOI: (10.1016/j.chembiol.2015.12.009) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 2 Improving Cas9 Specificity through Protein and Guide RNA Engineering (A) The D10A mutation in S. pyogenes Cas9 converts the protein from a DNA nuclease to a DNA nickase (Cas9n) with the ability to cleave only the strand complementary to the gRNA. A pair of Cas9n-gRNA nickases programmed to nick opposite strands at nearby locations as indicated by the arrowheads can induce double-stranded breaks that leads to NHEJ and HDR at levels similar to that of wild-type Cas9, but with improved specificity due to the requirement of two adjacent nicking events. (B) By fusing FokI to a catalytically dead Cas9 (fCas9), DNA cleavage only occurs when two fCas9 monomers assemble at adjacent DNA sites to form a catalytically active FokI nuclease. (C) Compared with a canonical single-guide RNA (sgRNA) that contains 20 nucleotides complementary to the target, trugRNAs contain shortened regions of target complementarity of 17–19 nucleotides while ggX20-gRNA adds two extra mismatched guanine nucleotides to the 5′ end of the gRNA. Both changes can increase the specificity of Cas9:gRNA-mediated DNA cleavage. Cell Chemical Biology 2016 23, 57-73DOI: (10.1016/j.chembiol.2015.12.009) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 3 Small-Molecule-Controlled Cas9 Variants (A) A laboratory-evolved intein that only undergoes protein splicing in the presence of the cell-permeable small molecule 4-hydroxytamoxifen (4-HT) was inserted into Cas9. The presence of the intein disrupts Cas9 activity until treatment with 4-HT, which induces protein splicing and restores Cas9 activity. (B) After splitting Cas9 into an N-terminal fragment and a C-terminal fragment, an FKBP rapamycin binding (FRB) domain or FK506 binding protein (FKBP) was fused to the N-terminal fragment or C-terminal fragment, respectively. To decrease background activity, a nuclear export signal (NES) was added to the N-terminal fragment while two NLS signals were added to the C-terminal fragment. The addition of rapamycin induces dimerization of Cas9(N)-FRB-NES and Cas9(C)-FKBP-2xNLS, resulting in trafficking of the reassembled Cas9 protein to the nucleus, where it is able to target and cleave DNA. Cell Chemical Biology 2016 23, 57-73DOI: (10.1016/j.chembiol.2015.12.009) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 4 Light-Controlled Cas9 Variants (A) A photoactivatable Cas9 (paCas9) was created by fusing the photoswitchable proteins pMag or nMag, to the N-terminal fragment or C-terminal fragment, respectively, of a split Cas9 protein. Upon blue light irradiation, dimerization of pMag and nMag leads to activation of Cas9 and cleavage of target DNA. (B) In the light-activated CRISPR-Cas9 effector (LACE) system, a truncated version of CIB1 is fused to the N and C termini of Cas9, and CRY2 is fused to the transcriptional activation domain VP64. In the presence of blue light, CIB1 and CRY2 binding leads to localization of VP64 to the site of Cas9 binding and transcriptional activation. Cell Chemical Biology 2016 23, 57-73DOI: (10.1016/j.chembiol.2015.12.009) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 5 Intracellular Delivery of TALE and Cas9 Proteins Using Cationic Lipids (A) Proteins fused to supernegatively charged proteins such as (-30)GFP, or Cas9 protein complexed with gRNA, acquire a high degree of anionic charge. (B) Cationic lipids commonly used to transfect DNA and RNA can complex with the resulting highly anionic proteins or protein:RNA complexes, mediating their potent delivery into mammalian cells. Cell Chemical Biology 2016 23, 57-73DOI: (10.1016/j.chembiol.2015.12.009) Copyright © 2016 Elsevier Ltd Terms and Conditions